World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
98
Citations
49024
World Ranking
772
National Ranking
439

Medicine

D-Index
99
Citations
50498
World Ranking
8438
National Ranking
4362

Overview

Henry F. McFarland was affiliated with the National Institutes of Health in the United States. Their research primarily focused on medicine, with particular attention to pathology and forensic medicine, cell biology, oncology, nutrition and dietetics, and genetics.

The main topics covered in their work included multiple sclerosis research studies, skin and cellular biology research, polyomavirus and related diseases, trace elements in health, hemoglobinopathies and related disorders, endometrial and cervical cancer treatments, and the management of metastatic bone disease.

Frequent coauthors who collaborated with McFarland included Gary Cutter, Richard A. Rudick, Carl de Moor, Carol M. Singh, and Elizabeth Fisher.

Their publications appeared in several scientific venues. Notably, McFarland published in the following journals:

  • After Dinner Conversation
  • Multiple Sclerosis Journal - Experimental Translational and Clinical
  • American Journal of Neuroradiology
  • Neurology
  • International Journal of Radiation Oncology*Biology*Physics

A selection of recent papers authored or coauthored by McFarland includes:

  • Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial, 2023, Multiple Sclerosis Journal - Experimental Translational and Clinical
  • Manganese-Enhanced MRI in Patients with Multiple Sclerosis, 2020, American Journal of Neuroradiology
  • Serum neurofilament light-chain (sNfL) levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis (RRMS) patients in the CombiRx trial (2410), 2021, Neurology
  • Step Back, 2021, After Dinner Conversation
  • Sacrificing Mercy, 2022, After Dinner Conversation

Best Publications

  • Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis

    W. Ian McDonald;Alistair Compston;Gilles Edan;Donald E Goodkin

  • Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

    Chris H. Polman;Stephen C. Reingold;Gilles Edan;Massimo Filippi

  • Immunological aspects of demyelinating diseases

    Roland Martin;Henry F. McFarland;Dale E. McFarlin

  • Multiple sclerosis: a complicated picture of autoimmunity.

    Henry F McFarland;Roland Martin

  • Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

    Bibiana Bielekova;Bonnie Goodwin;Nancy Richert;Irene Cortese

  • Differential diagnosis of suspected multiple sclerosis: a consensus approach

    D. H. Miller;B. G. Weinshenker;M. Filippi;B. L. Banwell

  • The role of magnetic resonance techniques in understanding and managing multiple sclerosis

    D H Miller;R I Grossman;S C Reingold;H F McFarland

  • Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases

    Kevin G. Becker;Richard M. Simon;Joan E. Bailey-Wilson;Boris Freidlin

  • Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis

    Bibiana Bielekova;Marta Catalfamo;Susan Reichert-Scrivner;Amy Packer

  • Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.

    R Martin;H F McFarland

  • Multiple sclerosis (first of two parts).

    D E McFarlin;H F McFarland

  • Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

    Samantha S. Soldan;Rossana Berti;Nazi Salem;Paola Secchiero

  • Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients

    Paolo A. Muraro;Daniel C. Douek;Amy Packer;Katherine Chung

  • Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

    David Katz;Jeffery K. Taubenberger;Barbara Cannella;Dale E. McFarlin

  • Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

    Jerry S. Wolinsky;Ponnada A. Narayana;Paul O'Connor;Patricia K. Coyle

  • Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.

    Roland Martin;Dolores Jaraquemada;Marjorie Flerlage;John Richert

  • Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

    Henry F. McFarland;Joseph A. Frank;Paul S. Albert;Mary E. Smith

  • Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.

    Jonathan O. Harris;Joseph A. Frank;Joseph A. Frank;Nicholas Patronas;Nicholas Patronas;Dale E. McFarlin

  • The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

    Pascal Sati;Jiwon Oh;R. Todd Constable;Nikos Evangelou

  • The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

    Franz Fazekas;F. Barkhof;M. Filippi;R. I. Grossman

  • Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone

    Bernhard Hemmer;Burkhard T. Fleckenstein;Marco Vergelli;Günther Jung

Frequent Co-Authors

Roland Martin
Roland Martin University of Zurich
Dale E. McFarlin
Dale E. McFarlin National Institutes of Health
Joseph A. Frank
Joseph A. Frank National Institutes of Health
Steven Jacobson
Steven Jacobson National Institutes of Health
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
William E. Biddison
William E. Biddison National Institutes of Health
Bruno Gran
Bruno Gran University of Nottingham
Jerry S. Wolinsky
Jerry S. Wolinsky The University of Texas Health Science Center at Houston
Paul S. Albert
Paul S. Albert National Institutes of Health
Thomas A. Waldmann
Thomas A. Waldmann National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related online degrees and career pathways can open doors to diverse healthcare opportunities. Many professionals in immunology-related fields come from nursing backgrounds and may consider advancing their qualifications through specialized programs.

Nurses looking to advance can explore an fnp to acnp bridge program online, which offers a focused transition from Family Nurse Practitioner to Acute Care Nurse Practitioner roles. This pathway provides targeted training relevant to critical care and immunological assessment.

For accelerated options, aspiring nurse practitioners might find value in accelerated np programs online, designed to fast-track clinical expertise, often integrating foundational immunological concepts.

Individuals without a nursing background can start with online bsn programs for non nurses that provide essential nursing education remotely, paving the way to immunology-related specialties later.

For those who want to enter the nursing field quickly, 12-month accelerated nursing programs offer condensed curricula, allowing students to rapidly acquire credentials necessary for careers involving immunological research or patient care.

Best Scientists Citing Henry F. McFarland

Recently Published Articles